Evaluation of Factors That Increase the Risk of Hepatotoxicity in Patients Using Palbociclib and RibociclibBy admin / September 1, 2026 Cite this article Download PDF DOI Email Share Serdar Ata, Filiz Araz, Timuçin Çil, Berna Bozkurt Duman Volume 6 · Issue 2 · pp. 224–228 Published: 2023-08-31 Full text The full text of this article is available through the PDF link. Cite this article Copy APACopy VancouverCitation BibTeXRIS / EndNote APA Vancouver Previous articleEvaluating YouTube as a Resource for Postherpetic Neuralgia Patient Education Next articleEfficacy of Enhanced Recovery after Surgery (ERAS) Protocols in Lumbar Microdiscectomy Surgery